Stay updated with breaking news from Mark Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Extended Stay America, Inc....
(1) Vancouver, British Columbia--(Newsfile Corp. - March 16, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce today that its sponsored research collaboration with The Metabolomics Innovation Centre (TMIC) was successful in receiving funding from the Novel Technology Application in Cancer Prevention and Early Detection Spark Grants competition. This comes after the organizers of the competition, the Canadian Cancer Society/Canadian Institutes of Health Research - Institute of Cancer Research, and Brain Canada Foundation, evaluated the...
U.S. stock futures were mixed Monday as the 10-year Treasury yield held near 1-year highs.
TOP NEWS SUMMARY: AstraZeneca and Oxford insist Covid-19 jab is safe Mon, 15th Mar 2021 11:00 (Alliance News) - The following is a summary of top news stories Monday. COMPANIES The director of the Oxford Vaccine Group said there was no link between the jab it developed with Anglo-Swedish pharmaceutical giant AstraZeneca and blood clotting, after several countries suspended its use. Andrew Pollard said there was "very reassuring evidence that there is no increase in a blood clot phenomenon here in the UK, where most of the doses in Europe been given so far". "It's absolutely critical that we d...
BioMark Diagnostics, Inc.: BioMark Grants Options Vancouver, British Columbia--(Newsfile Corp. - March 2, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that it has granted 2,100,000 incentive stock options under the Company's Stock Option Plan ("Option Plan") to third-party consultants to support market communication and corporate strategy as it advances its commercialization efforts. Each option is exercisable into one common share at a price of $0.25 per share and will vest immediately. The options will expire two years from the ...